Global Dry Eye Disease Market Growth 2023-2029

Global Dry Eye Disease Market Growth 2023-2029

Dry eye disease is a multifactorial disease which is characterized by insufficiency of tears in eye. Insufficient lubrication in eye lead to burning, sensing, redness and pain in eye.

LPI (LP Information)' newest research report, the “Dry Eye Disease Industry Forecast” looks at past sales and reviews total world Dry Eye Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Dry Eye Disease sales for 2023 through 2029. With Dry Eye Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Eye Disease industry.

This Insight Report provides a comprehensive analysis of the global Dry Eye Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Eye Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Dry Eye Disease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Eye Disease and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Eye Disease.

The global Dry Eye Disease market size is projected to grow from US$ 2345.3 million in 2022 to US$ 2825.6 million in 2029; it is expected to grow at a CAGR of 2825.6 from 2023 to 2029.

United States market for Dry Eye Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Dry Eye Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Dry Eye Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Dry Eye Disease players cover Santen Pharma, Novartis, Llergan, Takeda, TRB Chemedica, Sun Pharmaceutical, Senju Pharmaceutical, Sentiss Pharma and Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Dry Eye Disease market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Artificial Tears
Anti-inflammatory Drugs
Other

Segmentation by application
Hospital
Drug Stores
Online Pharmacies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Santen Pharma
Novartis
Llergan
Takeda
TRB Chemedica
Sun Pharmaceutical
Senju Pharmaceutical
Sentiss Pharma
Johnson & Johnson
Otsuka
Mitotech
FCI
Altacor
Valeant Pharmaceuticals
United Laboratories
Jianfeng Group
Eusan GMBH

Key Questions Addressed in this Report

What is the 10-year outlook for the global Dry Eye Disease market?

What factors are driving Dry Eye Disease market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Dry Eye Disease market opportunities vary by end market size?

How does Dry Eye Disease break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.